Mobile, tablet, photo, watch, drone /Tablet accessories /iPad /Bag/Case
    • SPIGEN ULTRA HYBRID PRO IPAD Air 11 (2025) case standing Skin effect FLIP pencil holder ROZÉARANY

    SPIGEN ULTRA HYBRID PRO IPAD Air 11 (2025) case standing Skin effect FLIP pencil holder ROZÉARANY

    The Spigen Ultra Hybrid Pro case is made of leather-effect material for iPad Air 11 (2025/2026) and iPad Pro 11 (2022). The FLIP design case opens to the side, can be folded into three parts with the...
    Warranty
    We undertake an accessory warranty for the product, which according to the Civil Code is 2 years for consumers, otherwise 1 year.
    NOT ON STOCK
    The product is not available. Please click on the button to receive a notification if it is available again.

    Substitute products

      Product description

      The Spigen Ultra Hybrid Pro case is made of leather-effect material for iPad Air 11 (2025/2026) and iPad Pro 11 (2022). The FLIP design case opens to the side, can be folded into three parts with the TRIFOLD system, so it can also be used as a table holder.

      The case has a built-in pencil holder that allows you to conveniently store and carry the Apple Pencil. The standing position is ideal for typing, watching videos or drawing.

      In its rose gold color design, it provides an elegant appearance while providing full protection against scratches and bumps. Its weight is only 36 grams, so it does not make the device heavy.

      NOTEBOOK SEARCH

      Notebook search

      NOTEBOOK SEARCH

      OPINIONS

      0.0

      No opinions about this product

      Help others. Tell us what you think about the item.
      The information present here are the ones provided by the manufacturer. These can change without notice. Please inquire before the order, due to te fact that afterwards we cannot asume responsibility! The above images are illustrations. The product might differ in appearance. Our company has no item stock. The purchase is only possible after a previous order. The items list refers to our provider's stock.
      Back to the top of the page